Open Access

ARTICLE

mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance

CHIWEN BU^1,2, LIGANG ZHAO¹, LISHAN WANG¹, ZEQIAN YU¹, JIAHUA ZHOU^1,*

1 Department of Hepatobiliary and Pancreatic Surgery, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China
2 School of Medicine, Southeast University, Nanjing, 210009, China

* Corresponding Author: JIAHUA ZHOU. Email: